Parkinson's disease (PD) is a neurodegenerative disorder caused by the loss of neurons in
the substantia nigra pars compacta and a striatal deficiency of dopamine. PD typically affects …

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the
degeneration of the dopamine producing neurons projecting from the substantia nigra into …

Cell replacement therapy in Parkinson's disease (PD) has so far been based on the use of
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …

Motor dysfunctions in Parkinson's disease are considered to be primarily due to the
degeneration of dopaminergic neurons in the substantia nigra pars compacta …

Abstract Parkinson's disease (PD), one of the most frequent neurodegenerative disorders, is
primarily caused by the selective degeneration of specific neuronal populations, particularly …

Parkinson's disease is one of the most common neurodegenerative diseases caused by the
loss of dopaminergic neurons in the substantia nigra pars compacta. Pharmacological …

In Parkinson's disease (PD), the main pathology is a loss of nigrostriatal dopamine (DA)
neurons. Clinical trials with intrastriatal transplantation of human embryonic mesencephalic …

A major neuropathological feature of Parkinson's disease (PD) is the loss of nigrostriatal
dopaminergic neuron. Patients exhibit motor symptoms, including bradykinesia, rigidity, and …

Clinical studies with intrastriatal transplants of human embryonic mesencephalic tissue have
provided proof-of-principle for the cell replacement strategy in Parkinson's disease (PD) …

Parkinson's disease (PD) is the second most common neurodegenerative disease
worldwide, classically characterized by a triad of motor features: bradykinesia, rigidity and …